Prog Histochem News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prog Histochem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prog Histochem Today - Breaking & Trending Today

AstraZeneca Ultomiris granted approval in US for treatment of adults with neuromyelitis optica spectrum disorder

Published: March 25, 2024

Ultomiris, the first long-acting C5 complement inhibitor, shows promise in reducing relapse risk for AQP4 Ab+ NMOSD patients. Learn more here.

Source: directorstalkinterviews.com

Related Topics:

United KingdomNew ZealandUnited StatesNeuromyelitis OpticaHistochem CytochemEuropean UnionDrug AdministrationAlexion Pharmaceuticals IncNorth AmericaExpanded Disability Status Scale ScoreAstrazeneca Rare DiseaseAlexion PharmaceuticalsRare DiseasesAnn NeurolCurr Treat OptionsSouth EastNat RevProg HistochemNeuromyelitis Optica Spectrum Disorder UsingSafety StudyAdult Participants With